Glyco-Phospho-Glycero Ether Lipids (GPGEL): Synthesis and evaluation as small conductance Ca2+-activated K+ channel (SK3) inhibitors

MedChemComm

Volumn 3, Issue 11, 2012, Pages 1471-1478

  Sevrain, Charlotte M ^a   Haelters, Jean Pierre ^a   Chantôme, Aurélie ^b   Couthon Gourvès, Hélène ^a   Girault, Alban ^b   Vandier, Christophe ^b   Jaffrès, Paul Alain ^a  

^a UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^b UNIVERSITÉ DE TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 O HEXADECYL 2 O METHYL GLYCER 3 YL 2,3,4,6 TETRA O ACETYL ALPHA DEXTRO GALACTOPYRANOSYL (1-4) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 1 O HEXADECYL 2 O METHYL GLYCER 3 YL 2,3,4,6 TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL (1-4) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 1 O HEXADECYL 2 O METHYL GLYCER 3 YL 2,3,4,6 TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL (1-6) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 1 O HEXADECYL 2 O METHYL GLYCER 3 YL ALPHA DEXTRO GALACTOPYRANOSYL (1-6) ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 1 O HEXADECYL 2 O METHYL GLYCER 3 YL ALPHA DEXTRO GLUCOPYRANOSYL (1-4) ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 1 O HEXADECYL 2 O METHYL GLYCER 3 YL BETA DEXTRO GALACTOPYRANOSYL (1-4) ALPHA,BETA DEXTRO GLUCOPYRANOSYLPHOSPHATE TRIETHYLAMMONIUM SALT; 2,3,4,6 TETRA O ACETYL ALPHA DEXTRO GLUCOPYRANOSYL (1-4) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYL HYDROGENPHOSPHONATE, TRIETHYLAMMONIUM SALT; 2,3,4,6 TETRA O ACETYL ALPHA DEXTRO GLUCOPYRANOSYL (1-6) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYL HYDROGENPHOSPHONATE, TRIETHYLAMMONIUM SALT; 2,3,4,6 TETRA O ACETYL BETA DEXTRO GALACTOPYRANOSYL (1-4) 2,3,6 TRI O ACETYL ALPHA,BETA DEXTRO GLUCOPYRANOSYL HYDROGENPHOSPHONATE, TRIETHYLAMMONIUM SALT; EDELFOSINE; ETHER LIPID; GLYCOPHOSPHOGLYCERO ETHER LIPID; GLYCOPHOSPHOLIPID; LACTOSE; MALTOSE; MELIBIOSE; PHOSPHATE; SMALL CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; UNCLASSIFIED DRUG;

ARTICLE; CELL MOTILITY; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; PATCH CLAMP; PRIORITY JOURNAL;

EID: 84867952113     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c2md20207g     Document Type: Article

References (42)

1. C. D. Magnusson G. G. Haraldsson Chem. Phys. Lipids 2011 164 315 340
2. B. Z. Ngwenya D. M. Foster Proc. Soc. Exp. Biol. Med. 1991 196 69 75
3. F. Pedrono B. Martin C. Leduc J. Le Lan B. Saiag P. Legrand J. P. Moulinoux A. B. Legrand Nutr. Cancer 2004 48 64 69
4. M. P. Haynes H. R. Buckley M. L. Higgins R. A. Pieringer Antimicrob. Agents Chemother. 1994 38 1523 1529
5. J. L. Hammond D. L. Koontz H. Z. Bazmi J. R. Beadle S. E. Hostetler G. D. Kini K. A. Aldern D. D. Richman K. Y. Hostetler J. W. Mellors Antimicrob. Agents Chemother. 2001 45 1621 1628
6. E. A. Homan Y.-G. Kim J. P. Cardia A. Saghatelian J. Am. Chem. Soc. 2011 133 5178 5181
7. J. Graessler D. Schudke P. E. H. Schwarz R. Herzog A. Shevchenko S. R. Bornstein PLoS One 2009 4 e6261 1 13
8. S. J. Friedberg M. Halpert J. Lipid Res. 1978 19 57 64
9. A. L. Deniau P. Mosset D. Le Bot A. B. Legrand Biochimie 2011 93 1 3
10. E. Skopinska-Rozewska M. Krotkiewski E. Sommer E. Rogala M. Filewska B. Bialas-Chromiec K. Pastewka H. Skurzak Oncol. Rep. 1999 6 1341 1343
11. R. Andreesen Prog. Biochem. Pharmacol. 1988 22 118 131
12. M. Lohmeyer R. Bittman Drugs Future 1994 19 1021 1037
13. W. J. Houlihan M. Lohmeyer P. Workman S. H. Cheon Med. Res. Rev. 1995 15 157 223
14. W. R. Vogler J. Liu O. Volpert E. W. Ades N. Bouck Cancer Invest. 1998 16 549 553
15. F. J. Candal D. C. Bosse W. R. Vogler E. W. Ades Cancer Chemother. Pharmacol. 1994 34 175 178
16. T. Oskarsson P. Nagorny I. J. Krauss L. Perez M. Mandal G. Yang O. Ouerfelli D. Xiao M. A. Moore J. Massague S. J. Danishefsky J. Am. Chem. Soc. 2010 132 3224 3228
17. K. Lirdprapamongkol J. P. Kramb T. Suthiphongchai R. Surarit C. Srisomsap G. Dannhardt J. Svasti J. Agric. Food Chem. 2009 57 3055 3063
18. F. Calvo L. Agudo-Ibanez P. Crespo BioEssays 2010 32 412 421
19. D. Meitar S. E. Crawford A. W. Rademaker S. L. Cohn J. Clin. Oncol. 1996 14 405 414
20. J. L. Marshall S. Baidas P. Bhargava N. Rizvi IDrugs 2000 3 518 524
21. M. Egeblad Z. Werb Nat. Rev. Cancer 2002 2 161 174
22. G. Sala F. Dituri C. Raimondi S. Previdi T. Maffucci M. Mazzoletti C. Rossi M. Iezzi R. Lattanzio M. Piantelli S. Iacobelli M. Broggini M. Falasca Cancer Res. 2008 68 10187 10196
23. A. Hoffman B. Qadri J. Frant Y. Katz S. R. Bhusare E. Breuer R. Hadar R. Reich J. Med. Chem. 2008 51 1406 1414
24. G. A. Storme W. E. Berdel W. J. van Blitterswijk E. A. Bruyneel G. K. De Bruyne M. M. Mareel Cancer Res. 1985 45 351 357
25. D. C. Schallier E. A. Bruyneel G. A. Storme P. Hilgard M. M. Mareel Anticancer Res. 1991 11 1285 1292
26. H. K. Haugland S. J. Nygaard O. B. Tysnes Anticancer Res. 1999 19 149 156
27. M. Potier A. Chantôme V. Joulin A. Girault S. Roger P. Besson M. Jourdan J. Y. LeGuennec P. Bougnoux C. Vandier Br. J. Pharmacol. 2011 162 464 479
28. A. Fischer D. Müller M. Zimmermann-Kordmann B. Kleuser M. Mickeleit S. Laabs W. Löwe F. Cantagrel W. Reutter K. Danker ChemBioChem 2006 7 441 449
29. G. Semini A. Hildmann H. U. Reissing W. Reutter K. Danker Biochem. Pharmacol. 2011 81 985 995
30. A. Girault J. P. Haelters M. Potier-Cartereau A. Chantome P. A. Jaffrès P. Bougnoux V. Joulin C. Vandier Curr. Med. Chem. 2012 19 697 713
31. M. Potier V. Joulin S. Roger P. Besson M. L. Jourdan J. Y. Leguennec P. Bougnoux C. Vandier Mol. Cancer Ther. 2006 5 2946 2953
32. A. Chantome A. Girault M. Potier C. Collin P. Vaudin J. C. Pages C. Vandier V. Joulin Exp. Cell Res. 2009 315 3620 3630
33. M. J. Coghlan W. A. Carroll M. Gopalakrishnan J. Med. Chem. 2001 44 1627 1653
34. H. Wulff A. Kolski-Andreaco A. Sankaranarayanan J. M. Sabatier V. Shakkottai Curr. Med. Chem. 2007 14 1437 1457
35. H. Wulff B. S. Zhorov Chem. Rev. 2008 108 1744 1773
36. W. E. Berdel U. Fink J. Rastetter Lipids 1987 22 967 969
37. A. Girault J. P. Haelters M. Potier A. Chantôme M. Pineau S. Marionneau-Lambot T. Oullier G. Simon H. Couthon-Gourvès P. A. Jaffrès V. Joulin B. Corbel P. Bougnoux C. Vandier Curr. Cancer Drug Targets 2011 11 1111 1125
38. S. Chittaboina B. Hodges Q. Wang Lett. Org. Chem. 2006 3 35 38
39. A. J. Ross I. A. Ivanova M. A. J. Ferguson A. V. Nikolaev J. Chem. Soc., Perkin Trans. 1 2001 72 81
40. A. V. Nikolaev I. V. Botvinko A. J. Ross Carbohydr. Res. 2007 342 297 344
41. T. J. Martin G. Dufner B. Kratzer R. R. Schmidt Glycoconjugate J. 1996 13 547 553
42. J. J. Plattner R. D. Gless H. Rapoport J. Am. Chem. Soc. 1972 94 8613 8615